Connect with us

Business

Pfizer to seek COVID-19 vaccine approval ‘within days’ as trial shows jab 95 per cent effective – PerthNow

Pfizer and BioNTech COVID-19 vaccine could be submitted for approval ‘within days’ as a final trial reveals it is 95 percent effective. US authorities say it could…

Published

on

post featured image
ADVERTISEMENT

Pfizer Inc and BioNTech could secure emergency US and European authorisation for their COVID-19 vaccine next month after final trial results showed a 95 per cent success rate and no serious side effects.
The vaccine’s efficacy was found to be consistent across different ages and ethnicities – a promising sign given the disease has disproportionately hurt the elderly and certain groups including black people.
The US Food and Drug Administration could grant emergency-use by the middle of December,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending